Mark W. Garrison
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- Antibiotic Resistance in Bacteria 9
- Pharmacology 14
- Antibiotics Pharmacokinetics and Efficacy 13
- Co-authors
- John C. Rotschafer (11 shared papers)Douglas Michael Campbell (3 shared papers)Jeffrey D. Anderson (2 shared papers)Keith A. Rodvold (4 shared papers)Donald E. Anderson (4 shared papers)John E. Eiland (3 shared papers)Randy D. Pryka (3 shared papers)John P. Toscano (2 shared papers)
- Journals
- Diagnostic Microbiology and Infectious Disease (5 papers)Therapeutic Drug Monitoring (4 papers)Antimicrobial Agents and Chemotherapy (3 papers)Clinical Therapeutics (3 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Mark W. Garrison
33 papers receiving 922 citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 228
- Clinical Biochemistry 252
- Applied Microbiology and Biotechnology 43
- Endocrinology 114
- Infectious Diseases 328
Countries citing papers authored by Mark W. Garrison
This map shows the geographic impact of Mark W. Garrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark W. Garrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark W. Garrison more than expected).
Fields of papers citing papers by Mark W. Garrison
This network shows the impact of papers produced by Mark W. Garrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark W. Garrison. The network helps show where Mark W. Garrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark W. Garrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 236 | |
| 2 | 1990 | 96 | |
| 3 | 1998 | 92 | |
| 4 | 1996 | 81 | |
| 5 | 1989 | 46 | |
| 6 | 2005 | 45 | |
| 7 | 1989 | 42 | |
| 8 | 2009 | 41 | |
| 9 | 1997 | 39 | |
| 10 | 1998 | 30 | |
| 11 | 2006 | 29 | |
| 12 | 1989 | 22 | |
| 13 | 1990 | 20 | |
| 14 | 2021 | 17 | |
| 15 | 2012 | 17 | |
| 16 | 2003 | 15 | |
| 17 | 2006 | 15 | |
| 18 | 1989 | 13 | |
| 19 | 1988 | 10 | |
| 20 | 1997 | 10 |
About Mark W. Garrison
Mark W. Garrison is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Epidemiology and Endocrinology, having authored 33 papers that have together received 991 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (13 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (9 papers), Antimicrobial Resistance in Staphylococcus (7 papers), Bacterial Identification and Susceptibility Testing (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Advanced Statistical Process Monitoring (2 papers) and Infections and bacterial resistance (2 papers). The work is most often cited by research in Molecular Medicine (228 citations), Clinical Biochemistry (252 citations), Applied Microbiology and Biotechnology (43 citations), Endocrinology (114 citations) and Infectious Diseases (328 citations). Mark W. Garrison has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include John C. Rotschafer, Douglas Michael Campbell, Jeffrey D. Anderson, Keith A. Rodvold, Donald E. Anderson, John E. Eiland, Randy D. Pryka, John P. Toscano, Kyle Vance‐Bryan and T. A. Larson. Their work appears in journals such as Diagnostic Microbiology and Infectious Disease, Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, Clinical Therapeutics and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.